and Aims: Empirical use of fluoroquinolones (FQs) prior to tuberculosis (TB) diagnosis may improve the initial clinical symptoms and delay the initiation of anti-tuberculosis therapy. This study aimed to investigate the impact of the duration of FQ use prior to TB diagnosis on clinical outcomes in northern Taiwan.
prior to tuberculosis (TB) diagnosis may improve the initial clinical symptoms and delay the initiation of anti-tuberculosis therapy. This study aimed to investigate the impact of the duration of FQ use prior to TB diagnosis on clinical outcomes in northern Taiwan.
Methods: 306 TB patients were diagnosed at Tri-Service General Hospital, Taipei, Taiwan between 2013 and 2015. Groups of patients who were exposed to FQ for at least 7 days or for less than 7 days prior to TB diagnosis were defined as long-term FQ ( days; LT-FQ) and short-term FQ (ST-FQ) groups, respectively.
Results: Long term FQ exposure prior to TB diagnosis significantly increased the risk of mortality (Odds ratio = 3.00; 95% CI for OR = 1.21-7.47). Of the 306 patients identified, 21 (6.86%) were in the LT-FQ group and 285 (93.14%) were in the ST-FQ group. Compared to the ST-FQ group, patients in LT-FQ group were older (LT-FQ vs ST-FQ = 75 vs 62); with a decreased positive rate of acid-fast bacilli (AFB) smear in initial sputum examinations (19% vs 41%) and increased rate of mortality (43% vs 20%). The rate of TB PCR tests performed was significantly lower in LT-FQ group than in ST-FQ group (43% vs 68%; P = 0.02). However, there are no significantly differences between the rates of TB cultures (91% vs 86%) and TB PCR (89% vs 75%).
Conclusion:
Fluoroquinolone exposure for at least 7 days prior to tuberculosis diagnosis is associated with a lower rate of positive AFB smears and a higher rate of mortality. TB PCR could be a good method for patients with a history of FQ use. Background and Aims: Cardiovascular-related comorbidities are known contributors to morbidity and mortality in COPD. Zinc homeostasis has vital physiological functions throughout the body and we have shown its dysregulation in the epithelium in response to cigarette smoke. Its role however, in mechanisms underlying vasculature dysfunction/inflammation in COPD are unknown. We hypothesized that zinc flux may also regulate signalling pathways in the microvasculature in COPD. As a first step in tackling this hypothesis we analyzed the expression of proteins responsible for zinc homeostasis in endothelium and smooth muscle of human microvasculature. Immunolocalization was related with components of the eNOS/MAPK axis, the key regulators in vasculature physiology and COPD.
Cell and Molecular Biology
Methods: Microvessels were isolated from adipose tissue biopsies donated by 12 non-smoker patients undergoing hernia surgery. Expression/localization of zinc transporters (ZIPs, isoforms 1, 2, 4, 8, 12 and 14), zinc binding/storage proteins metallothioneins (MTs, isoforms 1/2 and 3), eNOS, and p38 MAPK (including their phosphorylated isoforms) were investigated by immunofluorescence and confocal microscopy and ImageJ quantification.
Results: In the human microvasculature, the endothelium was found to be the major harbour of all tested ZIPs (ZIP1, ZIP8, ZIP12, ZIP4, ZIP14 and ZIP2, in order of brightness), with abundant expression of p38 MAPK and eNOS. ZIPs were less abundantly in the smooth muscle, revealing mostly nuclear patterns. Metallothioneins however showed brighter immunofluorescence in the smooth muscle than endothelium. Furthermore the active forms of eNOS (Ser1177-phosphorylated) and p38 MAPK (Thr180/ Tyr182-phosphorylated) were localized to different compartments of the microvasculature, with eNOS-P mostly in the smooth muscle but p38 MAPK-P in the endothelium. Correlation analyses are pending. 
Methods:
To elucidate the AT2 cell-specific function of MFN1 and MFN2, we employed an inducible knockout strategy to selectively delete MFN1 and MFN2 genes in adult murine AT2 cells. We further examined whether loss of MFN1 or MFN2 in AT2 cells could potentiate bleomycininduced pulmonary fibrosis. Multidisciplinary approaches, including ultrastructural and histology examination, transcriptomic and lipidomic analyses, were applied to explore the mechanisms. 
